-
In a decision more than 10 years in the making, a U.S. Federal District judge ruled April 5, 2013, that the Food and Drug Administration (FDA) must lift age and point-of-sale restrictions on Plan B One-Step emergency contraception (EC) within 30 days.
-
Results of a just-published study indicate a possible method to predict when a woman will have her final menstrual period.1 Such findings might be helpful in aiding women and providers in combatting potential bone loss and cardiovascular risk associated with onset of menopause.
-
Women over age 40 might underestimate their need for effective birth control; however, despite declining fertility, such women can be at risk for unintended pregnancy.
-
With the recent Food and Drug Administration approval of Quartette, a new extended regimen oral contraceptive (OC) from Teva Pharmaceuticals of North Wales, PA, providers have more options to present to women considering this form of birth control.
-
While teen pregnancies are declining in the United States, the nation still leads the worlds high-income countries in live teen births, points out a recent Centers for Disease Control and Prevention (CDC) Public Health Grand Rounds session.1
-
The Food and Drug Administration (FDA) is adding a boxed warning to the drug label of codeine-containing products to address a known safety concern with codeine use in certain children after tonsillectomy and/or adenoidectomy.
-
A recently reported case of hepatitis B virus transmission from a chronically infected surgeon to as many as eight patients underscores the need for providers to know their HBV status and seek the counsel of an expert review panel if they perform invasive or so called exposure-prone procedures, public health officials emphasize.
-
Concerns about cases involving provider liability should not deter clinicians from off-label prescribing, says Samantha L. Prokop, Esq., an attorney with Brennan, Manna & Diamond, in Akron, OH.
-
When was the last time you updated your antiquated policies and unimaginable procedures? Do you even have a policy that address tweets? No, you dont.
-
Facilities accredited by the Accreditation Association for Ambulatory Health Care (AAAHC) have new requirements as of March 1, 2013, including one to document all outcomes related to adverse reactions to drugs and materials.
